Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew B Ward

Showing results (71-80 of 493) with videos related to

Pageof 50
Sort By:
Research Square|March 3, 2023
Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralizationPhilippe Colin, Rajesh P Ringe, Anila Yasmeen, et al.
Biorxiv : the Preprint Server for Biology|May 22, 2023
Evolving spike-protein <i>N</i>-glycosylation in SARS-CoV-2 variantsSabyasachi Baboo, Jolene K Diedrich, Jonathan L Torres, et al.
Cell Reports|April 11, 2019
The HIV-1 Envelope Glycoprotein C3/V4 Region Defines a Prevalent Neutralization Epitope following ImmunizationLin Lei, Yuhe R Yang, Karen Tran, et al.
Journal of Chemical Information and Modeling|October 22, 2024
CosolvKit: a Versatile Tool for Cosolvent MD Preparation and AnalysisNiccolo' Bruciaferri, Jerome Eberhardt, Manuel A Llanos, et al.
Journal of Virology|April 20, 2018
Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers <i>In Vitro</i>Gabriel Ozorowski, Albert Cupo, Michael Golabek, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Structural and Functional Insights into the Evolution of SARS-CoV-2 KP.3.1.1 Spike ProteinZiqi Feng, Jiachen Huang, Sabyasachi Baboo, et al.
Plos Pathogens|August 4, 2016
Thermostability of Well-Ordered HIV Spikes Correlates with the Elicitation of Autologous Tier 2 Neutralizing AntibodiesYu Feng, Karen Tran, Shridhar Bale, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2025
Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogensYen Thi Kim Nguyen, Xueyong Zhu, Julianna Han, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2014
Structures of protective antibodies reveal sites of vulnerability on Ebola virusCharles D Murin, Marnie L Fusco, Zachary A Bornholdt, et al.
Cell Reports|July 6, 2025
Structural and functional insights into the evolution of SARS-CoV-2 KP.3.1.1 spike proteinZiqi Feng, Jiachen Huang, Sabyasachi Baboo, et al.
Pageof 50

Showing results (71-80 of 493) with videos related to

Sort By:
Pageof 50
Research Square|March 3, 2023
Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralizationPhilippe Colin, Rajesh P Ringe, Anila Yasmeen, et al.
Biorxiv : the Preprint Server for Biology|May 22, 2023
Evolving spike-protein <i>N</i>-glycosylation in SARS-CoV-2 variantsSabyasachi Baboo, Jolene K Diedrich, Jonathan L Torres, et al.
Cell Reports|April 11, 2019
The HIV-1 Envelope Glycoprotein C3/V4 Region Defines a Prevalent Neutralization Epitope following ImmunizationLin Lei, Yuhe R Yang, Karen Tran, et al.
Journal of Chemical Information and Modeling|October 22, 2024
CosolvKit: a Versatile Tool for Cosolvent MD Preparation and AnalysisNiccolo' Bruciaferri, Jerome Eberhardt, Manuel A Llanos, et al.
Journal of Virology|April 20, 2018
Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers <i>In Vitro</i>Gabriel Ozorowski, Albert Cupo, Michael Golabek, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Structural and Functional Insights into the Evolution of SARS-CoV-2 KP.3.1.1 Spike ProteinZiqi Feng, Jiachen Huang, Sabyasachi Baboo, et al.
Plos Pathogens|August 4, 2016
Thermostability of Well-Ordered HIV Spikes Correlates with the Elicitation of Autologous Tier 2 Neutralizing AntibodiesYu Feng, Karen Tran, Shridhar Bale, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2025
Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogensYen Thi Kim Nguyen, Xueyong Zhu, Julianna Han, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2014
Structures of protective antibodies reveal sites of vulnerability on Ebola virusCharles D Murin, Marnie L Fusco, Zachary A Bornholdt, et al.
Cell Reports|July 6, 2025
Structural and functional insights into the evolution of SARS-CoV-2 KP.3.1.1 spike proteinZiqi Feng, Jiachen Huang, Sabyasachi Baboo, et al.
Pageof 50